Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-04-26
1994-11-15
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142242, 5142305, 514278, 514299, 514305, 514413, 540582, 544 47, 544105, 546 15, 546112, 546126, 546133, 546183, C07D45104, A61K 3146
Patent
active
053648633
ABSTRACT:
This invention provides bicyclic carboxylic esters and amides, their pharmaceutical formulations, and a method for their use in treating migraine, emesis, gastrointestinal disorders, schizophrenia, or anxiety in mammals.
REFERENCES:
patent: 3860619 (1975-01-01), Christensen et al.
patent: 4329459 (1982-05-01), McCall
patent: 4486441 (1984-12-01), Fozard et al.
Gazz. Chim. Ital., 3(9-10), 383 (1981).
Occelli et al., Chem. Abst., vol. 96, 142391 (1982).
Rorer, Chem. Abst., vol. 99, 53792 (1983).
Christensen et al., Chem. Abst. (II), vol. 78, 147774 (1973).
Serban et al., Chem. Abst., vol. 84, 59722 (1976).
Cohen Marlene L.
Lacefield William B.
Robertson David W.
Conrad Robert A.
Dentz Bernard
Eli Lilly and Company
LandOfFree
Specific 5-HT.sub.3 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Specific 5-HT.sub.3 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Specific 5-HT.sub.3 antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1097966